Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SRPT
SRPT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SRPT News
Biotech Investment Environment Improves
May 20 2026
Fool
Analysis of Biotech Companies' Prospects
May 20 2026
NASDAQ.COM
Sarepta to Participate in RBC Healthcare Conference
May 13 2026
Newsfilter
FDA Commissioner's Departure Triggers Biotech Market Reactions
May 13 2026
Newsfilter
FDA Leadership Shakeup May Impact Biotech Stocks
May 08 2026
stocktwits
Sarepta Therapeutics Q1 2026 Earnings Call Insights
May 07 2026
seekingalpha
Sarepta's Q1 Results Beat Expectations but Shares Drop
May 06 2026
stocktwits
Sarepta Therapeutics Q1 Results Beat Expectations Despite Stock Decline
May 06 2026
seekingalpha
Sarepta Therapeutics Q1 Earnings Exceed Expectations
May 06 2026
seekingalpha
Sarepta Therapeutics to Report Q1 2026 Financial Results
Apr 22 2026
Newsfilter
Transformation of Value in Biotechnology Sector
Apr 20 2026
Globenewswire
Biotechnology Sector Undergoes Value Transformation
Apr 20 2026
Newsfilter
Roche Initiates New Phase 3 Trial for Elevidys Gene Therapy
Apr 16 2026
seekingalpha
Capricor's Former Executive Considered for FDA Biologics Chief
Apr 14 2026
stocktwits
SAREPTA THERAPEUTICS INC: RBC Increases Target Price from $18 to $19
Apr 07 2026
moomoo
SAREPTA THERAPEUTICS, INC.: DEUTSCHE BANK INCREASES TARGET PRICE FROM $12 TO $14
Mar 26 2026
moomoo
Show More News
